Bimatoprost (marketed in the U.S. Canada and Europe by Allergan under the trade name Lumigan) is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. In December 2008 the indication to lengthen eyelashes was approved by the U.S.
This page contains content from the copyrighted Wikipedia article "Bimatoprost"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
